Navigation Links
Later Use of Clot-Buster After Stroke Possible: Study
Date:9/14/2008

tPA can be safely given beyond the current 3-hour limit, international researchers find

SUNDAY, Sept. 14 (HealthDay News) -- European researchers who showed that the clot-dissolving drug tPA could safely be used within three hours after a stroke now say the limit can be extended to four-and-a-half hours.

"We now have a three-hour limit mandated by authorities," said Dr. Nils Wahlgren, a neurology professor at the Karolinska Institute in Sweden and leader of an international group reporting Sunday in the online version of The Lancet. "Our data indicate that it is safe to extend that from three hours to four-and-a-half hours. The risk of hemorrhagic complications is not significantly different from the earlier time limit."

Tissue plasminogen activator (tPA), also known as the drug alteplase, is the approved treatment for the most common kind of stroke, in which a blood clot blocks a brain artery. The three-hour post-stroke time limit has been set because of fears that use of the clot-dissolving drug beyond that period might cause dangerous bleeding or other complications.

The new report is the latest from a study requested by European authorities after doubts arose about the safety of tPA in stroke treatment, which was approved in 1996 by the U.S. Food and Drug Administration. It was approved in 2002 in Europe.

The study compared the outcomes of 664 people who were given tPA between three and four-and-a-half hours after a stroke against almost 12,000 who received the drug within three hours of an attack.

The study found a death rate of 12.7 percent in the following three months for the three-hour group and 12.2 percent for those getting tPA later. In the early group, 58 percent achieved the ability of independent action, compared to 56.3 percent in the later-administration group.

"We recorded no significant differences between the 3- to 4.5-hour cohort and the within 3-hour cohort for any outcome measure," the researchers reported.

The bottom line, according to Wahlgren: "if patient treatment has been delayed, it is still safe to treat a patient beyond the time limit of three hours."

The results were expected to be presented at an international meeting in Stockholm in November, "when we will recommend a change in the guidelines," Wahlgren said. "I expect it would be accepted by the international community, both in the United States and Europe, and in the rest of the world."

But the new results do not necessarily mean an end to the three-hour limit, cautioned Dr. Larry Goldstein, professor of neurology at Duke University and director of the Duke Stroke Center in Durham, N.C.

"They are consistent with a combined analysis done some time ago that suggested we might be able to treat beyond three hours," Goldstein said. "But those were observational studies, as was this one. Controlled trials done to test that belief have not shown benefit."

It will take a change in the current guidelines to alter the three-hour limit, he said, and the overall benefit of tPA is greater when it is given earlier. "The sooner you get blood to the brain, the better," Goldstein said.

More information

There's more on tPA at the American Heart Association.



SOURCES: Nils Walhgren, M.D., professor, neurology, Karolinska Institute, Stockholm, Sweden; Larry Goldstein, M.D., professor of neurology, Duke University, Durham, N.C.; Sept. 14, 2008, The Lancet online


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. 6 Years Later, 9/11 Health Questions Linger
2. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
3. SBi Launches rHead(TM) Lateral Radial Head Implant and rHead(TM) Plating Systems to Expand its Elbow Management System
4. Early treatment of children with bilateral amblyopia essential, according to multisite study
5. AAAAI: Early Day Care Attendance May Protect Infants From Later Developing Asthma, From the Journal of Allergy and Clinical Immunology
6. Dementia in More Educated Hits Later But Harder
7. Contamination from depleted uranium found in urine 20 years later
8. Early Weight Gain Can Mean Heart Trouble Later in Life
9. Fetal heart rate yields clues to childrens later development
10. Fetal Heart Rate Points to Later Child Development
11. Trauma earlier in life may affect response to stress years later
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Later Use of Clot-Buster After Stroke Possible: Study
(Date:5/6/2016)... ... ... wide variety of national pet product manufacturers, companies and brands will gather for one day ... from noon to 8 p.m. at New York City’s Roger Smith Hotel. The event is ... outdoor and safety pet products in today’s marketplace. , Petrend Event showcases the ...
(Date:5/6/2016)... ... May 06, 2016 , ... ... reduce fat areas around the body, is the most popular among body sculpting ... released make perfect sense to cosmetic surgeon Dr. Richard Buckley, medical director of ...
(Date:5/6/2016)... ... May 06, 2016 , ... From May 4 to 6, EarQ ... unique opportunity to learn more about Signia’s technology and the successful business and marketing ... our priority to see practices succeed in this highly competitive industry,” said Ed Keller, ...
(Date:5/6/2016)... ... 06, 2016 , ... The International Yoga Teacher Training schoo l ... island close to the town famous for its sunsets, Oia. This all inclusive yoga ... to have an amazing experience in Greece, we just can’t stay away” says Co-Founder ...
(Date:5/6/2016)... ... ... and Overseer at The House of Yahweh, has written a new article this week meant ... to stop cancer. Yisrayl says there are too many suffering and dying from the disease ... will pay close attention and take action. The Pastor says that the root cause of ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... JERUSALEM , May 4, 2016 ... University of Jerusalem announced today that it had ... BioTheryX, Inc. , developer of novel protein degradation ... the development and commercialization of drug candidates representing first-in-class ... the license were not disclosed. The novel ...
(Date:5/4/2016)... May 4, 2016 ... the  "Global Acute Ischemic Stroke Market and ... their offering.       (Logo: ... Acute Ischemic Stroke Market and Competitive Landscape ... Ischemic Stroke pipeline products, Acute Ischemic Stroke ...
(Date:5/3/2016)... 2016 Global Insulin Needles ... 09 key companies and supported with 272 tables ... study on the current state of the Insulin ... industry including definitions, classifications, applications and industry chain ... for the international market including development history, competitive ...
Breaking Medicine Technology: